References
[1]鄢小建,姚咏明,董宁,于燕,陆家齐,盛志勇.脓毒症大鼠多脏器Toll样受体4基因表达的改变及意义[J].中华肝胆外科杂志,2005,11(1): 31-34.
[2]张金萍,陈超,杨毅.Toll样受体2和4在新生儿感染时的变化及其临床意义[J].中华儿科杂志,2007,45(2):130-133.
[3]Auestad N, Korsak RA, Bergstrom JD, Edmond J. Milk-substitutes comparable to rat's milk, their preparation, composition and impact on development and metabolism in the artificially reared rat[J]. Br J Nutr, 1989, 61(3):495-518.
[4]Le Mandat Schultz A, Bonnard A, Barreau F, Aigrain Y, Pierre-Louis C, Berrebi D, et al. Expression of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of necrotizing enterocolitis[J]. PLoS One, 2007, 2(10):e1102.
[5]Medzhitov R, Janeway C Jr. The Toll receptor family and microbial recognition[J]. Trends Microbiol, 2000, 8(10): 452-456.
[6]Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling[J]. Nature, 2004, 430(6996): 257-263.
[7]Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640): 394-397.
[8]Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide[J]. J Immunol, 2001, 167(3): 1609-1616.
[9]Jilling T, Simon D, Lu J, Meng FJ, Li D, Schy R, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis[J]. J Immunol, 2006, 177(5):3273-3282.
[10]Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma[J]. Lancet, 1998, 352(9130):772-776.
[11]Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence[J]. Crit Care Med, 2002, 30(9): 2022-2029.
[12]常晓,王琳琳,连淑君,唐清,陈萍,王华.谷氨酰胺对内毒素血症幼鼠肠屏障的保护作用[J].中国当代儿科杂志,2010,12(10):809-811.
[13]Kessel A, Toubi E, Pavlotzky E, Mogilner J, Coran AG, Lurie M, et al. Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat[J]. Clin Exp Immunol, 2008, 151(2): 341-347.
[14]Larson SD, Li J, Chung DH, Evers BM. Molecular mechanisms contributing to glutamine-mediated intestinal cell survival[J].Am J Physiol Gastrointest Liver Physiol, 2007, 293(6): G1262-G1271.
[15]Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut[J]. J Immunol, 2003, 170(8):3977-3985.